Article
Genotype-specific features reduce the susceptibility of South American yellow fever virus strains to vaccine-induced antibodies.
Cell host & microbe - 9 Feb 2022
Haslwanter Denise, Lasso Gorka, Wec Anna Z, Furtado Nathália Dias, Raphael Lidiane Menezes Souza, Tse Alexandra L, Sun Yan, Stransky Stephanie, Pedreño-Lopez Núria, Correia Carolina Argondizo, Bornholdt Zachary A, Sakharkar Mrunal, Avelino-Silva Vivian I, Moyer Crystal L, Watkins David I, Kallas Esper G, Sidoli Simone, Walker Laura M, Bonaldo Myrna C, Chandran Kartik
Abstract excerpt
The resurgence of yellow fever in South America has prompted vaccination against the etiologic agent, yellow fever virus (YFV). Current vaccines are based on a live-attenuated YF-17D virus derived from a virulent African isolate. The capacity of these vaccines to induce neutralizing antibodies against the vaccine strain is used as a surrogate for protection. However, the sensitivity of genetically distinct South...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
